APOTEA - ReversalTargets and secure buy levels
Reverse Head and Sholders and Fib 0.5: 83
Fibo 0.6: 84
Q4 will be released on 6th of February.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
214.90 M SEK
6.54 B SEK
39.61 M
About APOTEA AB
Sector
Industry
CEO
Pär Johan Svärdson
Website
Headquarters
Stockholm
Founded
2003
ISIN
SE0023313762
FIGI
BBG01R0WBNP8
Apotea AB engages in the provision of an online pharmacy that sells a range of both non-prescription and prescription drugs. It offers medicine for allergy, face, animal, fever and pain, cold, parent and child, aids and accessories, skin and hair, health food, hands and feet, stomach and intestine, mouth and teeth, travel packaging, stop smoking, wound, training and weight, vitamins and minerals, and eye and ear. The company was founded by Marie-Louise Jansson, Pär Johan Svärdson, and Susanne Söderberg in 2003 and is headquartered in Stockholm, Sweden.
APOTEA - Low probability for a short term Apotea is willing to visit lower levels as much as it can.
It can be an opportunity to buy.
APOTEA - Pull back and continue upwardTwo tops created a resistance.
A correction to 84 - 82 levels is expected to be a good PRZ correction.
OMXSTO:APOTEA is looking forward to announcing the first financial statements.
APOTEA - 80 is the lowest limitTREND
We have very limited data yet.
Here is a short term analysis for bullish mode.
80 is the strongest support
Moving Averages
Analysis is on 1H timeframe, so we skip it
SUMMARY
Based on this analysis, a price action following the blue arrow is probable.
APOTEA - Short TermTREND
We have very limited data yet.
Here is a short term analysis for bullish mode.
AB fibo extension (CD) matches with XA fibo 0.886, so it will be the potential resistance.
Moving Averages
Analysis is on 1H timeframe, so we skip it
SUMMARY
Based on this analysis, a price action following
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of APOTEA is 76.37 SEK — it has increased by 2.08% in the past 24 hours. Watch APOTEA AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange APOTEA AB stocks are traded under the ticker APOTEA.
APOTEA stock has risen by 5.07% compared to the previous week, the month change is a 2.31% rise, over the last year APOTEA AB has showed a −0.50% decrease.
We've gathered analysts' opinions on APOTEA AB future price: according to them, APOTEA price has a max estimate of 82.00 SEK and a min estimate of 74.00 SEK. Watch APOTEA chart and read a more detailed APOTEA AB stock forecast: see what analysts think of APOTEA AB and suggest that you do with its stocks.
APOTEA reached its all-time high on Dec 9, 2024 with the price of 97.52 SEK, and its all-time low was 66.31 SEK and was reached on Apr 7, 2025. View more price dynamics on APOTEA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
APOTEA stock is 3.94% volatile and has beta coefficient of 0.12. Track APOTEA AB stock price on the chart and check out the list of the most volatile stocks — is APOTEA AB there?
Yes, you can track APOTEA AB financials in yearly and quarterly reports right on TradingView.
APOTEA AB is going to release the next earnings report on May 8, 2025. Keep track of upcoming events with our Earnings Calendar.
APOTEA earnings for the last quarter are 0.58 SEK per share, whereas the estimation was 0.43 SEK resulting in a 33.33% surprise. The estimated earnings for the next quarter are 0.53 SEK per share. See more details about APOTEA AB earnings.
APOTEA AB revenue for the last quarter amounts to 1.73 B SEK, despite the estimated figure of 1.70 B SEK. In the next quarter, revenue is expected to reach 1.74 B SEK.
No, APOTEA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, APOTEA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade APOTEA AB stock right from TradingView charts — choose your broker and connect to your account.